David Jin - 23 Sep 2024 Form 4 Insider Report for AVENUE THERAPEUTICS, INC. (ATXI)

Role: Interim PFO and COO
Signature: /s/ David Jin
Issuer symbol: ATXI
Transactions as of: 23 Sep 2024
Net transactions value: $0
Form type: 4
Filing time: 25 Sep 2024, 16:53:41 UTC
Previous filing: 12 Jul 2024
Next filing: 01 Oct 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ATXI	COMMON STOCK, PAR VALUE $0.0001	Award	$0	+65,000		$0.000000	65,000	23 Sep 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents an award of 65,000 restricted stock units which will vest in equal installments at September 30, 2024, December 31, 2024, September 23, 2025, and September 23, 2026. The shares underlying the restricted stock units will not be settled until the earlier of the tenth business day of January of the year following certain terminations of service of the Reporting Person from the Issuer and the consummation of a Change in Control event (as defined in the Avenue Therapeutics, Inc. 2015 Incentive Plan); the amount will be distributed in the form of the Issuer's common stock.

Content

Represents an award of 65,000 restricted stock units which will vest in equal installments at September 30, 2024, December 31, 2024, September 23, 2025, and September 23, 2026. The shares underlying the restricted stock units will not be settled until the earlier of the tenth business day of January of the year following certain terminations of service of the Reporting Person from the Issuer and the consummation of a Change in Control event (as defined in the Avenue Therapeutics, Inc. 2015 Incentive Plan); the amount will be distributed in the form of the Issuer's common stock.